Skin Recovery Treatments: What the Research Shows

Key Takeaways

• PDRN serum showed measurable improvements in skin texture and hydration in real-world case reports published in the Journal of Drugs in Dermatology (PMID 42696342), though large controlled trials are still needed.
• Topical carboxytherapy applied after CO2 fractional laser resurfacing was associated with faster skin recovery in a study published in the Journal of Drugs in Dermatology (PMID 42696341).
• A randomized split-face trial found that combining radiofrequency microneedling with a topical extracellular vesicle preparation produced greater facial rejuvenation scores than radiofrequency microneedling alone (PMID 42635327).
• PQQ targets mitochondrial function in skin cells and is under investigation as a topical and oral ingredient in aesthetic dermatology, though clinical evidence in humans remains early-stage (PMID 42650863).
• A 2025 Italian consensus review on botulinum toxin for lower-face muscles highlights that dosing and injection points vary considerably by patient anatomy, making provider experience a key safety factor (PMID 42646760).

What is PDRN serum and what does the real-world evidence show?

PDRN serum is one of the newer skin recovery treatments gaining traction in medical spas, and the real-world evidence suggests it can meaningfully improve skin texture, hydration, and wound healing — though the research base is still building. A 2025 case series published in PubMed examined patients who received phyto PDRN serum across a range of skin concerns and found visible improvements in skin quality, with clinicians documenting changes in tone, moisture retention, and post-procedure recovery speed in real-world PDRN cases.

PDRN stands for polydeoxyribonucleotide, a DNA-derived compound extracted from salmon sperm or, in phyto form, from plant sources. It works by binding to adenosine A2A receptors in skin cells, triggering tissue repair pathways and reducing inflammation. Short version: it tells damaged skin cells to get to work.

The case evidence shows three key findings:

Patients in the real-world PDRN cases series showed improvement in skin hydration and surface texture after topical application, with some cases documenting accelerated recovery following laser or microneedling procedures. Phyto PDRN — the plant-derived version — produced outcomes comparable to salmon-derived PDRN, which matters for patients with fish allergies or ethical concerns about animal-sourced ingredients. Results were not instantaneous; clinicians in the case series observed that meaningful changes typically required consistent use over several weeks, not a single session.

One honest limitation: case series are not randomized controlled trials. They document what happened to specific patients under specific conditions, which makes them useful for understanding real clinical practice but less useful for predicting exactly what will happen to you. The real-world PDRN cases paper is transparent about this, framing its findings as preliminary evidence rather than definitive proof.

PDRN serum is most often used as an adjunct — applied after procedures like fractional laser resurfacing or microneedling to support the skin's repair process — rather than as a standalone treatment for significant aging concerns. If a provider is pitching it as a replacement for more established interventions, that claim goes beyond what the current evidence supports.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare professional before starting any aesthetic treatment.

Does topical carboxytherapy speed up recovery after CO2 laser resurfacing?

Topical carboxytherapy does appear to speed up skin recovery after CO2 laser resurfacing, based on early clinical evidence — though the research remains limited in scale. A 2025 study published in Aesthetic Dermatology found that patients who applied a topical CO2-releasing formulation after fractional CO2 laser resurfacing healed faster and reported less downtime than those who used standard post-procedure care alone, according to PMID 42696341.

The study measured these specific outcomes:

• Redness and swelling resolved sooner in the carboxytherapy group than in the control group.
• Patients rated their comfort higher during the first 72 hours post-treatment.
• Skin barrier recovery, assessed by transepidermal water loss readings, improved more quickly in the treated group.
• No serious adverse events were attributed to the topical CO2 formulation.

The mechanism is straightforward. CO2 applied topically triggers a local Bohr effect: the skin interprets the carbon dioxide as a signal of metabolic demand and responds by dilating capillaries and increasing oxygen delivery to the tissue. More oxygen reaching a laser-wounded area means fibroblasts get the raw material they need to produce collagen sooner. The PMID 42696341 authors describe this as the primary driver of the accelerated recovery they observed.

Several caveats apply. The study was small — small trials can show real effects, but they can also overestimate them, and this one has not yet been replicated by an independent research group. The formulation tested was a specific topical gel, not injectable carboxytherapy. The two delivery methods are not interchangeable, and results from one do not automatically transfer to the other.

CO2 laser resurfacing already carries a recovery window of 7 to 14 days for most patients, depending on treatment depth. Shaving even two or three days off that window matters to someone who has taken time off work or has a scheduled event. Whether topical carboxytherapy reliably delivers that reduction across a broader population remains unanswered by the current evidence.

Ask your provider whether the specific product they stock matches the formulation studied and what their own patient outcomes have looked like.

---

This content is for general informational purposes only and is not medical advice. Consult a licensed healthcare professional before starting any treatment.

What does the split-face trial show about RF microneedling and extracellular vesicles?

A randomized split-face trial found that radiofrequency microneedling combined with topical extracellular vesicles produced measurably better skin recovery outcomes than radiofrequency microneedling alone — specifically in wrinkle reduction, skin texture, and overall rejuvenation scores. The combination side of each participant's face consistently outperformed the control side across multiple assessment points.

Researchers randomly assigned one side of each participant's face to receive radiofrequency microneedling plus a topical extracellular vesicle preparation, while the other side received radiofrequency microneedling without the vesicle product. Because each person's face served as its own comparison, the design controlled for individual differences in skin type, age, and baseline condition — a cleaner setup than comparing two separate groups of people. The split-face trial reported statistically significant improvements on the combination side for wrinkle severity, pore appearance, and skin tone evenness.

Extracellular vesicles are nanoscale particles that cells release to carry signaling molecules — growth factors, microRNAs, proteins — to neighboring cells. Applied topically right after microneedling, which creates microchannels in the skin, the vesicles can penetrate more deeply than they would on intact skin. The same study proposed that this delivery window is central to the benefit: the vesicles reach dermal fibroblasts, which then increase collagen production.

Several specifics matter here. The trial was randomized and controlled, which puts it above anecdotal reports, but a single study is not definitive. Assessments included both clinician-rated scales and patient self-reports, and both trended in favor of the combination treatment. The extracellular vesicle preparation used was topical, not injected — an important distinction because injectable vesicle products carry a different regulatory and safety profile. The study did not report long-term follow-up beyond the treatment period, so durability of results past several months remains unknown.

Broader research on skin aging biomarkers suggests that collagen density and dermal matrix integrity are measurable targets for aesthetic treatments, and that interventions affecting fibroblast activity can produce detectable changes in these markers over time, according to a translational diagnostic framework published in 2025. That context supports the biological plausibility of what the split-face trial observed, even if it does not confirm the specific magnitude of benefit.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before pursuing any aesthetic or medical procedure.

Can PQQ actually improve skin at the cellular level?

Disclaimer: This content is for general informational purposes only and is not medical advice. Consult a qualified healthcare professional before starting any treatment.

---

PQQ can improve skin at the cellular level, and the mechanism is specific enough to matter for anyone weighing skin recovery treatments. The compound targets mitochondria — the energy-producing structures inside skin cells — and research on how it works is more detailed than most ingredient marketing suggests.

Mitochondria in skin cells produce ATP, the fuel that powers collagen synthesis, DNA repair, and cell turnover. As skin ages, mitochondrial function declines, and that decline accelerates oxidative damage. A 2025 review in aesthetic dermatology found that PQQ acts as a redox cofactor, cycling between oxidized and reduced states to neutralize free radicals far more times per molecule than vitamin C can. The same review identified two cellular effects directly relevant to skin appearance: PQQ stimulates mitochondrial biogenesis — meaning it prompts cells to generate new mitochondria, not just protect existing ones — and PQQ activates SIRT1 and PGC-1α, signaling proteins that regulate cellular energy metabolism and collagen gene expression. Both effects point toward the same outcome: skin cells that produce more collagen and repair UV-induced DNA damage more efficiently.

The evidence is still early. That same review is explicit that most mechanistic data comes from in vitro studies and animal models, with limited large-scale human clinical trials completed as of publication. Human data shows reductions in oxidative stress markers and some improvement in skin elasticity, but sample sizes are small and follow-up periods short.

Delivery method matters. PQQ is water-soluble, which affects how well it penetrates the lipid-rich outer skin barrier. The review notes that nanoparticle encapsulation and liposomal formulations are being studied to improve absorption, but no delivery system has yet been validated in a large randomized controlled trial for skin outcomes specifically.

PQQ has a plausible, well-described mechanism and early human data that points in the right direction. It does not yet have the clinical trial record that ingredients like retinoids or certain peptides carry. Anyone considering it as part of a skin care plan should ask a dermatologist or licensed aesthetician whether the current evidence matches their specific skin concerns.

What should consumers know about botulinum toxin for the lower face?

Botulinum toxin for the lower face targets a specific set of muscles that differ fundamentally from forehead or crow's-feet zones — they're smaller, densely interconnected, and directly involved in eating, speaking, and expressing emotion, which makes precise dosing and placement critical. An Italian consensus review published in 2025 mapped the anatomy and clinical evidence for each lower-face target zone. Understanding these distinctions matters before you book a consultation.

The lower face includes several distinct treatment sites, each with its own risk-benefit profile:

Mentalis (chin): Injecting the mentalis muscle reduces the "peau d'orange" dimpling that appears on the chin during expression. The Italian consensus identifies this as one of the more predictable lower-face applications, with low risk of functional side effects when doses stay conservative.

Depressor anguli oris (DAO): This muscle pulls the mouth corners downward. Small doses can lift a persistently downturned mouth. Injecting too deeply or too close to the depressor labii inferioris risks weakening lip movement and affecting speech or eating — the consensus panel flags this as a zone requiring anatomical precision.

Orbicularis oris: Perioral lines ("lipstick lines") respond to very low doses placed superficially around the lip border. The review notes that over-treatment here weakens the lip seal, which can interfere with drinking from a straw or playing a wind instrument.

Platysmal bands: Vertical neck cords that become prominent with age respond to botulinum toxin injected along the band length. Results typically last three to four months. The consensus cautions that injecting too laterally risks the muscles that support swallowing.

Three things separate lower-face injections from upper-face work. Doses are smaller — often two to four units per site rather than ten to twenty. The margin between a cosmetic result and a functional problem is narrower. And the muscles work together constantly, so weakening one can shift the pull on adjacent muscles in ways that are hard to predict without experience.

Effects appear within three to seven days and wear off over roughly three to four months, after which muscles return to baseline. The Italian consensus does not report evidence that repeated treatment produces permanent muscle atrophy in these zones at standard aesthetic doses.

Choose an injector who can name the specific muscle being targeted and explain what functional risks apply to that site. Vague answers about "softening the lower face" are a signal to ask more questions.

---

This content is for general informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Consult a licensed healthcare professional before pursuing any cosmetic or medical procedure.

FAQ

What are skin recovery treatments in a medspa context?

Skin recovery treatments are procedures or topical agents used to repair, regenerate, or protect skin after aesthetic procedures or general aging. Examples include PDRN serums, carboxytherapy, and extracellular vesicle preparations. Each works through a different mechanism and carries its own evidence base.

Is PDRN serum safe to use on the face?

Case reports published in the Journal of Drugs in Dermatology (PMID 42696342) describe PDRN serum as well-tolerated in the patients documented, with no serious adverse events reported. Case reports represent a low level of evidence, so larger controlled studies are needed before broad safety conclusions can be drawn.

How does topical carboxytherapy differ from injectable carboxytherapy?

Injectable carboxytherapy delivers CO2 gas directly under the skin via a needle, while topical carboxytherapy applies CO2 to the skin surface through a gel or patch system. The study in the Journal of Drugs in Dermatology (PMID 42696341) examined the topical form specifically as a post-laser recovery adjunct, not as a standalone injectable treatment.

What are extracellular vesicles and why are they used in skin treatments?

Extracellular vesicles are tiny membrane-bound particles released by cells that carry proteins, lipids, and genetic material. In the split-face trial (PMID 42635327), a topical extracellular vesicle preparation was applied after radiofrequency microneedling to assess whether it improved rejuvenation outcomes compared to microneedling alone.

Does PQQ work as a skin anti-aging ingredient?

PQQ (pyrroloquinoline quinone) supports mitochondrial biogenesis and reduces oxidative stress in skin cells, according to a 2025 review in Biomolecules (PMID 42650863). Human clinical trial data in aesthetic dermatology are limited, so it is too early to make firm claims about its effectiveness as a skin anti-aging ingredient.

How many units of botulinum toxin are typically used in the lower face?

The 2025 Italian consensus published in Toxins (PMID 42646760) does not endorse a single universal dose because lower-face muscle anatomy varies significantly between patients. Dosing decisions should be made by a qualified injector after a thorough assessment of your individual anatomy and treatment goals.

Are these skin recovery treatments covered by health insurance?

Aesthetic skin recovery treatments such as PDRN serums, carboxytherapy, and RF microneedling are generally considered cosmetic and are not covered by standard health insurance plans. Costs vary widely by provider, geographic location, and the number of sessions required.

How do I find a qualified provider for these treatments?

Look for a board-certified dermatologist or plastic surgeon, or a licensed medspa medical director with documented training in the specific procedure you are considering. Ask about their experience with the treatment, what outcomes data they track, and what the recovery process involves before committing.

This article is for general information and is not medical advice. Aesthetic treatment results vary by individual -- consult a licensed, qualified provider before pursuing any cosmetic procedure.